Part: 12         Session: 145678910111213141516171819202122         Page 599600601602603604605606607608609610611612613614615616617618619620621622623624625626627628629630631632633634635636637638639640641642643644645646647648649650651652653654655656657658659660661662663 of 999

Yes. He always seemed to me very optimistic and cheerful about it. Does he get depressed?

He decided that he would try to overcome it. If anybody could overcome it, he would do it, but sometimes, people are just too -- the odds are too heavily against them. We'll unfortunately know -- or fortunately -- one or the other, know in the next few months.

Very, very soon.

I persuaded a friend, Dr. Jordan Gutterman, who is an outstanding cancer specialist in chemotherapy and immunotherapy of M. B. Anderson, to prepare an outline of of current clinical research in cancer, with chemotherapy and immunotherapy, and the first copy was available as of November 15th and another one has been available as of May 15th.

This is to be for --?

This is to be distributed to key doctors everywhere, but the exact distribution has not been decided on. If the people trying to treat cancer throughout the United States saw this, some of them probably would not use the drugs effectively or maybe poorly, but this at least makes an outline of who is using what and what results they have gotten, as far as the published literature and the literature that he knows of in press goes. And he's got the telephone numbers of all the doctors, so they could call up and ask the doctors listed, “when your article was published, I suppose, and sent in to the New England Journal twelve months ago ; are your figures still holding